Trending...
- House of Buneau Releases "Pretty Boy Heaven," A Cinematic Exploration of Beauty and Distance
- California and European Commission discuss cooperation to accelerate the global transition to a carbon-neutral, resilient, and equitable future
- KeysCaribbean Offers 'Skip-the-Crowds' Savings With 15 Percent Off April Stays
STOCKHOLM, Dec. 5, 2024 ~ Pixelgen Technologies, a leading company in cell surface proteomics for single cells, has announced its participation at the 66th American Society of Hematology Annual Meeting and Exposition (ASH) in San Diego, California. The event will take place from December 7-10 at the San Diego Convention Center.
The company's presence at ASH is highly anticipated as it will showcase new data from its collaborators that support the application of Pixelgen's patented Molecular Pixelation (MPX) technology and kit in various scientific research areas. This marks an expansion for the company into the field of hematology.
According to Pixelgen CEO Simon Fredriksson, Ph.D., the spatial mapping of cell surface proteins is crucial for hematology researchers as it provides unprecedented insights into the organization and function of these proteins. This can greatly benefit blood cell function and disease research, leading to advancements in diagnostics, personalized therapeutics, and next-generation treatments for blood cancers, immune dysregulation, and hematopoietic disorders.
"We're excited to be participating in ASH for the first time and sharing our groundbreaking technology with the hematology community," said Dr. Fredriksson.
More on The Californer
Pixelgen will be featured in two sessions during the event. Dr. Fredriksson will give an industry presentation titled "The Spatial Organization of Surface Proteins of Single Cells in Myelodysplastic Syndrome for Diagnostics and Drug Target Discovery By Molecular Pixelation." The presentation will include data from Dr. Aaron Viny of Columbia University and will take place on December 7 from 3:30-3:45 p.m. in Room 5B. Dr. Fredriksson will be joined by Dr. Viny during this session.
In addition, Dr. Jessica Nordlund, Associate Professor at Uppsala University's Molecular Precision Medicine research group, along with Dr. Maria Globisch, will present a poster titled "Mapping the Spatial Proteome of Individual Leukemia Cells Undergoing Fludarabine Treatment." This poster will be featured in session number 803 on December 7 from 5:30-9:30 p.m. in Halls G-H.
Attendees can also visit Pixelgen at Booth #2852 to learn more about the company's product and technology. Representatives will be available to discuss the latest data on identifying CAR-T cells and mapping their cell surface proteome for detailed mechanism of action studies. Additionally, Pixelgen has collaborated with Illumina to develop an Application Note that focuses on cancer-specific protein patterns of blood cancer cells, which will be available at the event.
The company's participation at ASH highlights its commitment to advancing research in hematology and providing innovative solutions for the scientific community. With its cutting-edge technology and collaborations with renowned institutions, Pixelgen is poised to make a significant impact in this field.
The company's presence at ASH is highly anticipated as it will showcase new data from its collaborators that support the application of Pixelgen's patented Molecular Pixelation (MPX) technology and kit in various scientific research areas. This marks an expansion for the company into the field of hematology.
According to Pixelgen CEO Simon Fredriksson, Ph.D., the spatial mapping of cell surface proteins is crucial for hematology researchers as it provides unprecedented insights into the organization and function of these proteins. This can greatly benefit blood cell function and disease research, leading to advancements in diagnostics, personalized therapeutics, and next-generation treatments for blood cancers, immune dysregulation, and hematopoietic disorders.
"We're excited to be participating in ASH for the first time and sharing our groundbreaking technology with the hematology community," said Dr. Fredriksson.
More on The Californer
- California: Governor Newsom announces judicial appointments 3.27.2026
- Legal Powerhouses, Dance Drama, and Romance: Meet the New Platform Debuting This April
- Pet Furniture Meets Interior Design: Wooffy Redefines the Role of Dog Homes in Modern Living Spaces
- City to Add No-Cost Preschool to West Facilities Center in West Long Beach
- Snell & Wilmer Attorneys Emily Cheung and Kina Wong Appointed Co-Leads of CALA-OC Young Lawyers Cmte
Pixelgen will be featured in two sessions during the event. Dr. Fredriksson will give an industry presentation titled "The Spatial Organization of Surface Proteins of Single Cells in Myelodysplastic Syndrome for Diagnostics and Drug Target Discovery By Molecular Pixelation." The presentation will include data from Dr. Aaron Viny of Columbia University and will take place on December 7 from 3:30-3:45 p.m. in Room 5B. Dr. Fredriksson will be joined by Dr. Viny during this session.
In addition, Dr. Jessica Nordlund, Associate Professor at Uppsala University's Molecular Precision Medicine research group, along with Dr. Maria Globisch, will present a poster titled "Mapping the Spatial Proteome of Individual Leukemia Cells Undergoing Fludarabine Treatment." This poster will be featured in session number 803 on December 7 from 5:30-9:30 p.m. in Halls G-H.
Attendees can also visit Pixelgen at Booth #2852 to learn more about the company's product and technology. Representatives will be available to discuss the latest data on identifying CAR-T cells and mapping their cell surface proteome for detailed mechanism of action studies. Additionally, Pixelgen has collaborated with Illumina to develop an Application Note that focuses on cancer-specific protein patterns of blood cancer cells, which will be available at the event.
The company's participation at ASH highlights its commitment to advancing research in hematology and providing innovative solutions for the scientific community. With its cutting-edge technology and collaborations with renowned institutions, Pixelgen is poised to make a significant impact in this field.
Filed Under: Business
0 Comments
Latest on The Californer
- LiposoMore™ Redefines Bioavailability: Joyful Nutritional Launches High-Performance Liposomal Vitamin C and Iron for the Global Supplement Market
- California: Governor Newsom strengthens bans on insider betting by state officials, takes aim at corruption fueled by Trump
- GDE Tree Services Expands Operations into Sydney, NSW
- Tuckwell Machinery Expands CNC Range to Support Australian Cabinet Makers
- "Dave Simmons of StrataX Development: Why AB1033 and SB9 Are About to Rewrite California Real Estate"
- The Inner Power of Emotional Self-Leadership
- Dr. Nadene Rose Shares the Secret to True Success: Faith, Obedience, and Divine Purpose
- California: Governor Newsom signs legislation 3.26.26
- VBO Expands Event Manager 3.0 with Real-Time Sales Visibility, New Dashboards, and Operational Tools
- eBook Publishing Services in USA California Book Publishers Helps Authors Turn Ideas into Successful
- City of Long Beach to Host Recycle Your Bicycle Event on May 2
- Public Employees Are Asking: Are Our Pensions Secure?
- Understanding Unexpected Death: Why Independent Autopsies Matter in Cases Without Clear Cause
- Epic Pictures Group Sets North American Release Date for the Thriller NO ORDINARY HEIST
- Drywall Repair Near Me Services Expand In Huntington Beach Orange County
- Mobile App Developers in California California Web Coders Builds High-Performance Apps for Modern Bu
- California Lutheran University Taps Pandemic Response Leader as Chief Strategy & Growth Officer
- For April Fools' Day: A poem about The Secret to Happiness! The secret is "Don't Say Nuthin'"
- Long Beach: Meredith Reynolds Appointed as Acting Director of Technology and Innovation Department
- California: Governor Newsom announces CHP crackdown: 12,600 arrests, 6,400 stolen cars recovered, 25 million deadly fentanyl doses seized in two years